Bill of Health

MAY 22, 2023

The selections feature topics ranging from an analysis of government and industry investments for recently approved drugs, to a discussion of court decisions on mifepristone, and an examination of the added therapeutic benefit associated with the top-selling brand-name drugs in Medicare. JAMA Health Forum. 2023 Apr 7;4(4):e230511.

Pharmaceutical Industry 157

Pharmaceutical Industry Medicare Medicare Medicaid 157

HIT Consultant

SEPTEMBER 14, 2023

Samm Anderegg, Co-Founder & CEO at DocStation Early next year, the Centers for Medicare and Medicaid Services (CMS) will remove the application of retroactive DIR fees and move DIR fees to the point of sale instead. Does it grow my revenue? Do my staff enjoy using it?

Pharmaceutical Industry 59

Pharmaceutical Industry Medicaid Medicaid Medicare 59

HIT Consultant

OCTOBER 20, 2023

can be attributed to falls, including approximately six percent of Medicare and eight percent of Medicaid expenditures. Fornari co-founded and was the CEO and medical director of Dominion Diagnostics, one of the country’s leading pharmaceutical monitoring laboratories and served there from 1997 to 2011.

Pharmaceutical Industry 105

Pharmaceutical Industry Public Health Medicaid Medicaid 105

Health Populi

MARCH 11, 2021

health care, patient assistance programs, Medicare Advantage plans, and the bundling of proven high-value preventive services into the Affordable Care Act. In the case of Medicare Part D, the drug benefit, Chandra said, “If you’re sick enough to fall into the donut hole, you may have higher mortality.”

Health Insurance 98

Health Insurance ACA Medicare Medicare 98

Fierce Healthcare

AUGUST 29, 2023

The Biden administration and federal regulators may be taking a victory lap following the unveiling of the Centers for Medicare & Medicaid Services’ (CMS') price negotiations list, but major pl | Critics of President Joe Biden's policies to rein in prices for 10 Medicare Part D drugs believe the policy is "draconian" and will (..)

Pharmaceutical Industry 96

Pharmaceutical Industry Medicare Medicare Medicaid 96

Hall Render

FEBRUARY 18, 2022

13-year Medicare payment dispute will return to HHS, court rules. Colorado mental health professionals incensed after Medicaid forum that was intended to clear the air. Florida health system settles improper Medicaid payment allegations for $5.5M. Medicaid Managed-Care Proposal Goes to Mississippi Senate. MISSISSIPPI.

COVID-19 40

COVID-19 Nursing Homes Nurses COVID-19 Vaccine 40

CMS.gov

NOVEMBER 26, 2018

Proposed Changes to Lower Drug Prices in Medicare Advantage and Part D. Medicare Part D. Proposed Changes to Lower Drug Prices in Medicare Advantage and Part D. Today the Centers for Medicare & Medicaid Services (CMS) announced proposed changes to Medicare Part D to lower prescription drug costs for beneficiaries.

Medicare 52

Medicare Medicare Pharmaceutical Industry Health Insurance 52